Gainers Buzz: Wal-Mart Stores, Inc. (NYSE:WMT), Astex Pharmaceuticals, Macy's, Inc. (NYSE:M), Abbott Laboratories (NYSE:ABT)

Lakeway, NY -- (SBWIRE) -- 03/05/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Wal-Mart Stores, Inc. (NYSE:WMT) surged up 2.12% and closed at $73.26. Wal-Mart Stores Inc. along with SunEdison has completed solar power installations at three Wal-Mart stores in Hawaii. The three Walmart stores of Kahului, Kailua-Kona and Kapolei will now be powered by renewable solar energy, generating more than 400,000 kilowatt hours of solar electricity in its first year of production and eliminating 320 metric tons of carbon dioxide annually.

Is WMT a Still a Buy after the Solid momentum? Let’s Find out Here

Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) increased 2.11% and closed at $3.38. Astex Pharmaceuticals has been upgraded by TheStreet Ratings from hold to buy. Astex Pharmaceuticals, Inc. engages in the discovery and development of small molecule therapeutics with a focus on oncology and hematology. It develops small molecule therapeutics using its fragment-based drug discovery platform, Pyramid.

Is ASTX a Strong Buying Opportunity After The Recent Slump? Find out Here

Macy's, Inc. (NYSE:M) moved up 2.11% and closed at $41.54. The judge overseeing a trial involving the two retailers said that J.C. Penney Co Inc. and Macy's Inc. should have settled their dispute over the rights to sell Martha Stewart products. The judge said that the trial could take longer than expected and he would not be influenced by the financial impact on the companies.

Should M Buy After The Recent Movement? Let’s Find out Here

Abbott Laboratories (NYSE:ABT) increased 2.11% and closed at $34.31. Abbott Laboratories has been reaffirmed by TheStreet Ratings as a hold with a ratings score of C. The Company is engaged in the discovery, development, manufacture, and sale of a portfolio of science-based health care products. Abbott operates in four business segments: diagnostics, medical devices, nutritionals and generic pharmaceuticals. Geographically, 30% of its revenue is generated in the United States; 30% in Western Europe, Canada, Japan and Australia, and 40% in the economies.

Should ABT Buy After The Recent Movement? Let’s Find out Here

About ThePennyStockProfiler.com
ThePennyStockProfiler.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. ThePennyStockProfiler.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.ThePennyStockProfiler.com

Disclaimer
The assembled information disseminated by ThePennyStockProfiler.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. ThePennyStockProfiler.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.